| RS532947142 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS532959204 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome 2 |
| RS532961259 |
PALLD
|
Health Risk |
Conflicting classifications of pathogenicity |
Pancreatic adenocarcinoma, Pancreatic adenocarcinoma |
| RS532963814 |
VWF
|
Health Risk |
Conflicting classifications of pathogenicity |
VWF-related disorder, VWF-related disorder |
| RS532964069 |
ASXL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS532964185 |
RAB3GAP1
|
Health Risk |
Pathogenic |
Warburg micro syndrome 1, Martsolf syndrome 2 |
| RS532966530 |
TSEN54
|
Health Risk |
Pathogenic |
— |
| RS532967850 |
CUL3
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudohypoaldosteronism type 2E, Pseudohypoaldosteronism type 2E |
| RS532983875 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Congenital contractural arachnodactyly |
| RS532989312 |
EFEMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa, autosomal recessive |
| RS532994978 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial heart block type IB, Cardiovascular phenotype |
| RS533000838 |
TRAPPC11
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type R18, Autosomal recessive limb-girdle muscular dystrophy type R18 |
| RS533003321 |
GPHN
|
Health Risk |
Likely pathogenic |
Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C, Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C |
| RS533026166 |
SHOC1
|
Health Risk |
Pathogenic |
Spermatogenic failure 75, Spermatogenic failure 75 |
| RS533027065 |
MYO7A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1B, Usher syndrome type 1B |
| RS533032986 |
SLC45A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculocutaneous albinism type 4, Oculocutaneous albinism type 4 |
| RS533033409 |
PNKD
|
Health Risk |
Conflicting classifications of pathogenicity |
Paroxysmal nonkinesigenic dyskinesia, Paroxysmal nonkinesigenic dyskinesia 1 |
| RS533039765 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS533055438 |
ACADVL
|
Health Risk |
Pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS533067936 |
NFIA
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS533071750 |
B3GALT6
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, spondylodysplastic type |
| RS533072680 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS533072942 |
EARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome, Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome |
| RS533076307 |
ETHE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ethylmalonic encephalopathy, Ethylmalonic encephalopathy |
| RS533088955 |
ACOX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS533090572 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS533092441 |
SLC24A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital stationary night blindness 1D, Congenital stationary night blindness 1D |
| RS533103813 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS533107164 |
RDX
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS533110479 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS533121927 |
XPC
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group C |
| RS533127847 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Osteogenesis imperfecta |
| RS533142740 |
OBSL1
|
Health Risk |
Conflicting classifications of pathogenicity |
3M syndrome 2, OBSL1-related disorder |
| RS533146473 |
SUCLG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial DNA depletion syndrome 9, Inborn genetic diseases |
| RS533151885 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
| RS533161794 |
COG4
|
Health Risk |
Conflicting classifications of pathogenicity |
COG4-congenital disorder of glycosylation, COG4-congenital disorder of glycosylation |
| RS533171147 |
TBCD
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome, Inborn genetic diseases |
| RS533171314 |
PRKDC
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency due to DNA-PKcs deficiency, Severe combined immunodeficiency due to DNA-PKcs deficiency |
| RS533172128 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS533192044 |
NR2E3
|
Health Risk |
Conflicting classifications of pathogenicity |
Enhanced S-cone syndrome, Retinitis pigmentosa |
| RS533208785 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS533210843 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS533214351 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, KMT2D-related disorder |
| RS533216340 |
SYNJ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-onset Parkinson disease 20, Developmental and epileptic encephalopathy |
| RS533221512 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS533231370 |
CLN6
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis, Inborn genetic diseases |
| RS533231493 |
GJB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 1A, Nonsyndromic genetic hearing loss |
| RS533231784 |
FREM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fraser syndrome 2, Fraser syndrome 2 |
| RS533233215 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS533236263 |
MASP1
|
Health Risk |
Pathogenic |
3MC syndrome 1, 3MC syndrome 1 |
| RS533237399 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Cardiovascular phenotype |
| RS533240590 |
FUCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fucosidosis, Inborn genetic diseases |
| RS533244094 |
EP300
|
Health Risk |
Conflicting classifications of pathogenicity |
EP300-related disorder, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS533247725 |
MAP2K2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiofaciocutaneous syndrome 4 |
| RS533251927 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS533264615 |
JAK2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS533273863 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS533275090 |
TAOK1
|
Health Risk |
Pathogenic |
TAOK1-related disorder, TAOK1-related disorder |
| RS533287773 |
RPS7
|
Health Risk |
Conflicting classifications of pathogenicity |
Diamond-Blackfan anemia 8, Diamond-Blackfan anemia 8 |
| RS533290092 |
NBAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Short stature-optic atrophy-Pelger-Huët anomaly syndrome, Short stature-optic atrophy-Pelger-Huët anomaly syndrome |
| RS533297350 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertensive disorder, Hematuria |
| RS533306015 |
JAG1
|
Health Risk |
Pathogenic |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS533310204 |
ABCB4
|
Health Risk |
Likely pathogenic |
Cholestasis, intrahepatic |
| RS533310477 |
CPLANE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 17, Orofaciodigital syndrome type 6 |
| RS533311848 |
PRDM5
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS533321924 |
SCN4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Potassium-aggravated myotonia, Hyperkalemic periodic paralysis |
| RS533328133 |
KCNQ3
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial neonatal |
| RS533330664 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS533331740 |
NEXN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 20, Dilated cardiomyopathy 1CC |
| RS533334893 |
ABCC2
|
Health Risk |
Likely pathogenic |
Dubin-Johnson syndrome, Dubin-Johnson syndrome |
| RS533335580 |
F11
|
Health Risk |
Likely pathogenic |
Plasma factor XI deficiency, Hereditary factor XI deficiency disease |
| RS533349333 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS533349856 |
ABCA12
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS533353353 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypokalemic periodic paralysis, type 1 |
| RS533361991 |
HNF4A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hyperinsulinism, Maturity-onset diabetes of the young type 1 |
| RS533369230 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Lymphatic malformation 6, Inborn genetic diseases |
| RS533384820 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS533389472 |
CPA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary pancreatitis, Hereditary pancreatitis |
| RS533393007 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS533403902 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS533405046 |
DLD
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate dehydrogenase complex deficiency, Leigh syndrome |
| RS533410461 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
| RS533419433 |
FIG4
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS533422156 |
ABCA4
|
Health Risk |
Pathogenic/Likely pathogenic |
Cone-rod dystrophy 3, Severe early-childhood-onset retinal dystrophy |
| RS533425606 |
CFAP74
|
Health Risk |
Pathogenic |
Ciliary dyskinesia, primary |
| RS533432746 |
LRP2
|
Health Risk |
Pathogenic |
— |
| RS533437573 |
ADAMTS17
|
Health Risk |
Conflicting classifications of pathogenicity |
Weill-Marchesani 4 syndrome, recessive |
| RS533441671 |
GHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Laron-type isolated somatotropin defect, Laron-type isolated somatotropin defect |
| RS533451404 |
GRN
|
Health Risk |
Conflicting classifications of pathogenicity |
GRN-related frontotemporal lobar degeneration with Tdp43 inclusions, Neuronal ceroid lipofuscinosis 11 |
| RS533470019 |
MUC5B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS533476140 |
SNTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome 12, Cardiovascular phenotype |
| RS533487249 |
RNU4ATAC
|
Health Risk |
Conflicting classifications of pathogenicity |
Lowry-Wood syndrome, RNU4ATAC spectrum disorder |
| RS533490795 |
UNC13D
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 3, Familial hemophagocytic lymphohistiocytosis 3 |
| RS533492555 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to DOCK8 deficiency, Inborn genetic diseases |
| RS533502309 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Acromicric dysplasia, Geleophysic dysplasia |
| RS533526600 |
IL18BP
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS533528646 |
COL7A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS533540262 |
FAH
|
Health Risk |
Pathogenic/Likely pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS533540279 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Usher syndrome type 2C |
| RS533540496 |
COL2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 1, Stickler syndrome |